This report describes neurodegeneration with brain iron accumulation 6, which shows autosomal recessive inheritance. The human gene implicated in this disease is COASY, which is sometimes called by its enzymatic functions, phosphopantetheine adenylyltransferase (PPAT) and dephospho-CoA kinase (DPCK), and is part of the Coenzyme A (CoA) synthesis pathway. There is a single high-ranking ortholog of COASY in Drosophila, Ppat-Dpck, for which RNAi-targeting constructs and alleles caused by insertional mutagenesis have been generated.
The human gene COASY has not been introduced into flies.
Ppat-Dpck loss-of-function mutants have reduced locomotor function (walking and initiating flight), which worsens as they age. They also show held-out and held-up wing positioning, indicative of abnormal indirect flight muscle contraction.
Loss of function of other members of the CoA synthesis pathway causes similar phenotype; see the report on neurodegeneration with brain iron accumulation (FBhh0000223) for more.
[updated Nov. 2020 by FlyBase; FBrf0222196]
Neurodegeneration with brain iron accumulation (NBIA) is a genetically heterogeneous disorder characterized by progressive iron accumulation in the basal ganglia and other regions of the brain, resulting in extrapyramidal movements, such as parkinsonism and dystonia. Age at onset, severity, and cognitive involvement are variable (review by Gregory et al., 2009; pubmed:18981035). [from MIM:234200; 2016.03.29]
[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6](https://omim.org/entry/615643)
[COENZYME A SYNTHASE; COASY](https://omim.org/entry/609855)
Neurodegeneration with brain iron accumulation (NBIA) is a group of inherited neurodegenerative disorders characterized by deposition of iron in the brain, mainly in basal ganglia. Clinical symptoms include progressive dystonia, spasticity, cognitive impairment, and neuropsychiatric abnormalities. Recently, mutations in the gene CoA synthase (COASY) have been identified as causative for a rare subtype of NBIA, COASY Protein‐Associated Neurodegeneration (CoPAN). CoPAN patients showed gait difficulties from early childhood, followed by oro‐mandibular dystonia, dysarthria, spastic‐dystonic paraparesis, parkinsonism, cognitive impairment, obsessive compulsive behavior, and axonal neuropathy. (Evers et al. 2017, pubmed:28489334.)
Neurodegeneration with brain iron accumulation refers to a group of neurodegenerative disorders characterized by progressive motor and cognitive dysfunction beginning in childhood or young adulthood. Patients show extrapyramidal motor signs, such as spasticity, dystonia, and parkinsonism. Brain imaging shows iron accumulation in the basal ganglia (summary by Dusi et al. 2014, pubmed:24360804). [from MIM:615643, 2020.11.17]
In vitro functional expression assays showed that the R499C mutant protein had lost DPCK enzymatic activity. Fibroblasts of both patients showed decreased levels of acetyl coenzyme A (CoA) and significantly decreased de novo production of CoA and dephospho-CoA, at about 20% of controls, consistent with a loss of function. The findings indicated that a defect in CoA biosynthesis can cause NBIA. (Dusi et al. 2014, pubmed:24360804). [from MIM:615643, 2020.11.17]
Higher eukaryotes depend on dietary pantothenate to produce CoA via the de novo CoA synthesis pathway. Pantothenate is phosphorylated to 4′-phosphopantothenate by pantothenate kinase (PANK). Next a cysteine is added by the 4′-phosphopantothenoylcysteine synthetase (PPCS) to form ( R )-4′-phospho- N -pantothenoylcysteine which is decarboxylated by ( R )-4′-phospho- N -pantothenoylcysteine decarboxylase (PPCDC) and produces 4′-phosphopantetheine. This 4′-phosphopantetheine receives an adenylyl group transferred from ATP mediated by 4′-phosphopantetheine adenylyltransferase (PPAT) and releases dephospho-CoA, which is then phosphorylated by dephospho-CoA kinase (DPCK) to finally yield CoA. (Bosveld et al. 2008, FBrf0205456.)
One to one: 1 human gene to 1 Drosophila gene.
Single, high-ranking ortholog of COASY.